Medwave,Inc.
MedWaves, Inc. is a San Diego-based private medical device company that develops the FDA-cleared AveCure Intelligent Therapeutic System, a microwave ablation platform for minimally invasive soft tissue treatment, sold to hospitals and interventional clinicians via capital equipment plus single-use consumables.
- Company typePrivate
- Founded1998
- HeadquartersSan Diego, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Medwave,Inc. does
MedWaves, Inc. is a privately held medical device company founded in 1998 and headquartered in San Diego, California. The company has developed the AveCure Intelligent Therapeutic System, a microwave ablation platform designed to deliver precisely controlled thermal energy for the treatment of soft tissue disease. MedWaves describes itself as the first company to use temperature and frequency-based feedback mechanisms in biomedical microwave energy delivery, with the core technical differentiator being an Intelligent Controller that modulates power pulse train and dynamically selects frequency (902-928 MHz) to adapt to changing tissue characteristics during therapy.
The AveCure platform consists of a capital equipment component (the Intelligent Controller/generator) and a family of single-patient-use accessories including rigid Smart Probes, a Super-Flex Smart Catheter, and a Hybrid Device with four available antenna sizes (1-4 cm active elements). The system operates within an adjustable 60-130°C temperature range, uses a built-in temperature sensor for closed-loop power control, and is designed to be plug-n-play with no cooling, no irrigation, and no return pads required. The platform is FDA 510(k) cleared for soft tissue coagulation/ablation, palliative treatment in spinal procedures via ablation of metastatic malignant lesions, and coagulation/ablation of tissue in bone during surgical procedures.
MedWaves sells directly to healthcare facilities including hospitals, surgical centers, and outpatient clinics, targeting general and oncological surgeons and interventional radiologists who perform soft-tissue tumor ablation procedures percutaneously, laparoscopically, or during open surgery. The revenue model combines one-time capital equipment sales with recurring single-patient-use consumables, and the company reports over 10,000 successful cases worldwide. Headcount is reported at 1-10 employees, no funding rounds or institutional investors are disclosed, and there is no information on named customer accounts, revenue, or leadership team beyond general contact emails.
Medwave,Inc. firmographics
Firmographics- Name
- Medwave,Inc.
- Legal name
- MedWaves, Inc.
- Website
- https://medwaves.com
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- MedWaves, Inc. is a San Diego-based private medical device company that develops the FDA-cleared AveCure Intelligent Therapeutic System, a microwave ablation platform for minimally invasive soft tissue treatment, sold to hospitals and interventional clinicians via capital equipment plus single-use consumables.
- Ownership category
- akta.pro rank
Medwave,Inc. industry classification
Industry- Product category
- Interventional Oncology Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser) (HLAHADAC)
- akta.pro secondary industries
- Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN), Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG)
Keywords
Where Medwave,Inc. is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Medwave,Inc. business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales, Others
Revenue model
- AveCure Intelligent Controller (Generator): Sale of the intelligent microwave generator/controller system - a capital equipment purchase for healthcare facilities.
- Single-Patient-Use Smart Catheters and Probes: Recurring consumable revenue from single-patient-use antennas, probes, and catheters used during ablation procedures. The company offers AveCure Smart Probe and AveCure Super-Flex Smart Catheter products.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Medwave,Inc. product offering
Product offeringCore offering
MedWaves designs and manufactures the AveCure Intelligent Therapeutic System, a microwave ablation platform that uses temperature and frequency-based feedback mechanisms to precisely and safely deliver microwave energy for coagulation and ablation of soft tissue. The offering comprises a capital intelligent controller/generator and single-patient-use smart catheters and probes (rigid probes, flexible catheters, and hybrid devices) used in percutaneous, laparoscopic, and intraoperative procedures.
Product overview
MedWaves offers the AveCure Intelligent Therapeutic System, a unified microwave ablation platform for soft tissue treatment. The system consists of an intelligent controller (generator) and an array of single-patient-use Smart catheters and probes (including rigid probes, flexible catheters, and hybrid devices). The platform is designed for percutaneous, laparoscopic, and intraoperative procedures, and can be used standalone or in conjunction with surgery, chemotherapy, and radiation therapy.
Differentiator
Problem solved
Functional benefit
Brands
- AveCure: AveCure Intelligent Therapeutic System - microwave ablation system consisting of an intelligent controller and single patient use Smart catheters and probes for soft tissue disease treatment.
Products and services
- AveCure Intelligent Controller The intelligent generator/controller that powers the AveCure microwave ablation system. It modulates power pulse train to control temperature and energy delivery, adapts dynamically to tissue changes during therapy, and provides adjustable temperature settings (60-130°C). Sold to hospitals, surgical centers, and outpatient facilities for use by surgeons and interventional radiologists.
- AveCure Smart Probe A rigid single-patient-use probe for the AveCure system with plug-n-play design, no cooling requirement, four antenna sizes (1, 2, 3, and 4 cm active elements) for matching treatment volume to lesion size, built-in temperature sensor for power control, and depth markers for precise positioning. Used by surgeons and interventional radiologists for soft tissue ablation procedures.
- AveCure Super-Flex Smart Catheter A flexible single-patient-use catheter for minimally invasive AveCure procedures. Features a plug-n-play design with a wide range of shaft lengths and flexibility options, and a built-in temperature sensor that enables power control with temperature feedback. Designed for interventional radiologists and surgeons performing minimally invasive soft tissue ablation.
- AveCure Hybrid Device A combination device with a rigid shaft and flexible body that offers the benefits of both rigid and flexible probe designs for various clinical applications within the AveCure platform. Used by surgeons and interventional radiologists for soft tissue ablation.
Quantifiable outcome
- Over 10,000 successful cases worldwide
- +1 more outcomes
Companies that use Medwave,Inc.
Customer profileSegments4 records
Ideal customer profiles2 records
Medwave,Inc. technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Medwave,Inc. partnerships and signals
Strategic signalScale indicators1 record
Recent moves4 records
Expansion highlights3 records
Medwave,Inc. competitors and assessment
Company assessmentDirect peers
- Medtronic: Markets the Emprint microwave ablation system, the dominant commercial competitor to MedWaves' AveCure in percutaneous and intraoperative tumor ablation. Both target interventional radiologists and surgeons with a generator-plus-consumable model.
- Boston Scientific: Offers the Microwave Ablation System (formerly Covidien) directly competing with AveCure in soft-tissue tumor ablation. Operates the same capital-plus-single-use-probe commercial model targeting the same clinical specialties.
- AngioDynamics: Markets the Solero Microwave Ablation System, a direct functional competitor in image-guided percutaneous tumor ablation. Targets the same interventional radiology customer base with overlapping soft-tissue ablation indications.
- Ethicon (Johnson & Johnson): Through its Neuwave acquisition, Ethicon offers a microwave ablation platform competing with MedWaves in soft-tissue tumor treatment. Leverages J&J's scale, GPO contracts, and global distribution to penetrate the same hospital accounts.
- Terumo: Markets microwave and RF ablation systems under its interventional oncology portfolio, directly overlapping MedWaves' tumor ablation use cases. Competes for the same interventional radiology and oncology surgery customers globally.
Broad incumbents
- Varian (Siemens Healthineers): A broad oncology medical device incumbent offering radiation, interventional, and ablation technologies. Competes in the same hospital oncology ecosystem as MedWaves, though Varian is not focused on microwave ablation specifically.
- Integra LifeSciences: Broad neurosurgical and surgical device incumbent with adjacent energy-based and ablation-adjacent offerings. Competes in overlapping surgical hospital channels and provides a strategic-acquisition reference point for MedWaves.
Emerging players
- Creo Medical: An emerging energy-based surgical device company with advanced energy platforms (Speedboat, MicroBlate) for GI and oncology applications. Comparable in scale and energy-device innovation strategy to MedWaves.
- EDAP TMS: Markets high-intensity focused ultrasound (HIFU) ablation systems, a non-invasive alternative to microwave ablation for soft-tissue tumors. Competes for the same patient population and interventional oncology budgets.
- SonaCare Medical: Focused ultrasound ablation developer targeting prostate and soft-tissue indications, an emerging competitor in the minimally invasive ablation space alongside MedWaves. Comparable size and emerging-company profile.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Medwave,Inc. social profiles
Digital presenceMedwave,Inc. compliance and trust
Trust signalCompliance1 record
Medwave,Inc. financial estimates
Financial estimateRevenue estimate
Valuation estimate
Medwave,Inc. leadership team
Management profileNumber of profiles
Medwave,Inc. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Medwave,Inc. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Medwave,Inc.
What does Medwave,Inc. do?
MedWaves designs and manufactures the AveCure Intelligent Therapeutic System, a microwave ablation platform that uses temperature and frequency-based feedback mechanisms to precisely and safely deliver microwave energy for coagulation and ablation of soft tissue. The offering comprises a capital intelligent controller/generator and single-patient-use smart catheters and probes (rigid probes, flexible catheters, and hybrid devices) used in percutaneous, laparoscopic, and intraoperative procedures.
Is Medwave,Inc. a public or private company?
Medwave,Inc. is a private company. It is classified as unknown and is currently operating.
When was Medwave,Inc. founded?
Medwave,Inc. was founded in 1998. It employs 1 to 10 people.
Where is Medwave,Inc. based?
Medwave,Inc. is headquartered in San Diego, United States, in the North America region.
How does Medwave,Inc. make money?
Two revenue lines are on record. AveCure Intelligent Controller (Generator) is the primary driver. The others are single-Patient-Use Smart Catheters and Probes.
Who are Medwave,Inc.'s main competitors?
Direct peers on record are Medtronic, Boston Scientific, AngioDynamics, Ethicon (Johnson & Johnson) and Terumo. Broad incumbents are Varian (Siemens Healthineers) and Integra LifeSciences. Emerging players are Creo Medical, EDAP TMS and SonaCare Medical.
Does Medwave,Inc. have an API?
No public API is recorded for Medwave,Inc..
What industry is Medwave,Inc. in?
Medwave,Inc.'s product category is Interventional Oncology Devices. Its primary akta.pro industry code is HLAHADAC, Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser), with a secondary code of HLAHADAN, Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools). Its NAICS code is 334510 and its SIC code is 3845.